Inhibition of Obesity-induced Lipotoxicity

Highlights

Nutritional supplement reduces cellular damage caused by exposure to high levels of fat Lipotoxicity inhibition in obese people effective without requiring weight loss Proof of effectiveness was demonstrated using a combination of three antioxidant compounds, already approved for human consumption , that resulted in a synergistic protective effect in animal models Treatment to help reduce risk of lipid-induced toxicity, a result of obesity, in heart, pancreatic, and muscle cells Our Innovation

Formulation of nutritional supplement, a combination of antioxidants, which significantly reduces cellular damage caused by exposure to high levels of fat

Key Features

Only pharmaceutical/ nutraceutical composition of matter that effectively inhibits lipid-induced toxicity in cells No toxic effects Administered orally or by injection Inexpensive development and production Development Milestones

Proof of concept in cell culture models and in animal models Seeking licensing agreements, strategic partnerships, joint ventures for commercialization The Opportunity

Overall market size in the U.S. in 2005 for products that reduce cell damage caused by oxidative stress estimated at $30 billion Product can be marketed as food supplement and as nutraceutical

Type of Offer: Licensing



« More Food Science Patents

---